Biotech News

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

PharmaCyte Biotech (PMCB)PharmaCyte Biotech2025-09-02 13:20 ESTPartnership

PMCB (PMCB) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is pmcb.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

MLYSMineralys Therapeutics2026-06-03 10:00 EST

Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing

REGNRegeneron Pharmaceuticals2026-05-18 11:00 EST

Regeneron Announces Strategic Collaboration with Parabilis Medicines to Advance Novel Antibody-Helicon™ Conjugates Across Multiple Therapeutic Areas

BMYBMYBristol-Myers Squibb Company2026-06-08 10:59 EST

Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the Disease

GSKGSK plc2026-05-11 12:00 EST

GSK enters exclusive collaboration with SBP Group, a market leader in hepatology in China, to accelerate bepirovirsen at launch

BMYBMYBristol-Myers Squibb Company2026-07-20 10:59 EST

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

BMEABiomea Fusion2026-06-03 12:00 EST

Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity

IDYAIDEAYA Biosciences2026-06-03 10:00 EST

IDEAYA Biosciences Announces Clinical Collaboration with Roche in MTAP-Deleted RAS-Mutant Pancreatic Cancer

ZNTLZentalis2026-07-17 20:15 EST

Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026

View all latest news

PharmaCyte Biotech

PharmaCyte Biotech was a biotechnology company focused on cell encapsulation and oncology before its restructuring and public-market decline. Its story centered on an experimental cancer-delivery platform.

Recent company news

PMCBPharmaCyte Biotech2025-11-25 14:15 EST

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

PMCBPharmaCyte Biotech2025-09-02 13:20 EST

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

PMCBPharmaCyte Biotech2025-08-20 13:15 EST

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

PMCBPharmaCyte Biotech2025-08-18 13:15 EST

PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

PMCBPharmaCyte Biotech2024-05-21 13:00 EST

PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease

Stock data

Close: 0.59 USD
Market cap: 8.06M USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States